Achmea Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.9M | Sell |
115,829
-15,448
| -12% | -$1.81M | 0.37% | 67 |
|
|
2026
Q1 | $15.8M | Sell |
131,277
-48,034
| -27% | -$5.55M | 0.42% | 60 |
|
|
2025
Q4 | $18.9M | Sell |
179,311
-438
| -0.2% | -$41.1K | 0.48% | 52 |
|
|
2025
Q3 | $15.1M | Buy |
179,749
+4,156
| +2% | +$342K | 0.19% | 140 |
|
|
2025
Q2 | $13.9M | Sell |
175,593
-7,220
| -4% | -$574K | 0.18% | 147 |
|
|
2025
Q1 | $16.4M | Buy |
182,813
+14,980
| +9% | +$1.4M | 0.24% | 122 |
|
|
2024
Q4 | $16.7M | Sell |
167,833
-24,270
| -13% | -$2.5M | 0.27% | 97 |
|
|
2024
Q3 | $21.8M | Buy |
192,103
+15,043
| +8% | +$1.79M | 0.36% | 69 |
|
|
2024
Q2 | $21.9M | Buy |
177,060
+12,249
| +7% | +$1.58M | 0.39% | 61 |
|
|
2024
Q1 | $21.7M | Sell |
164,811
-203,288
| -55% | -$25.1M | 0.41% | 62 |
|
|
2023
Q4 | $40.1M | Sell |
368,099
-47,998
| -12% | -$4.98M | 0.83% | 23 |
|
|
2023
Q3 | $42.8M | Buy |
416,097
+1,804
| +0.4% | +$194K | 0.93% | 17 |
|
|
2023
Q2 | $47.8M | Buy |
414,293
+60,681
| +17% | +$6.89M | 1.01% | 15 |
|
|
2023
Q1 | $37.6M | Buy |
353,612
+19,857
| +6% | +$2.14M | 1.09% | 13 |
|
|
2022
Q4 | $34.7M | Buy |
333,755
+430
| +0.1% | +$44K | 1.16% | 14 |
|
|
2022
Q3 | $28.7M | Buy |
333,325
+58,447
| +21% | +$5.22M | 1.02% | 15 |
|
|
2022
Q2 | $25.1M | Buy |
274,878
+29,730
| +12% | +$2.64M | 0.81% | 22 |
|
|
2022
Q1 | $20.1M | Buy |
+245,148
| New | +$19.3M | 0.52% | 33 |
|
|
2021
Q4 | – | Sell |
-237,443
| Closed | -$17.8M | – | 424 |
|
|
2021
Q3 | $17.8M | Sell |
237,443
-24,984
| -10% | -$1.9M | 0.54% | 34 |
|
|
2021
Q2 | $20.4M | Sell |
262,427
-81,889
| -24% | -$6.09M | 0.7% | 21 |
|
|
2021
Q1 | $25.3M | Buy |
344,316
+14,596
| +4% | +$1.08M | 0.88% | 15 |
|
|
2020
Q4 | $25.7M | Buy |
329,720
+32,812
| +11% | +$2.51M | 0.93% | 15 |
|
|
2020
Q3 | $23.5M | Sell |
296,908
-776,554
| -72% | -$60.8M | 0.98% | 15 |
|
|
2020
Q2 | $79.2M | Sell |
1,073,462
-177,935
| -14% | -$13.4M | 2.68% | 7 |
|
|
2020
Q1 | $91.9M | Buy |
1,251,397
+822,576
| +192% | +$64.6M | 4.21% | 2 |
|
|
2019
Q4 | $37.2M | Sell |
428,821
-2,609
| -0.6% | -$214K | 1.43% | 10 |
|
|
2019
Q3 | $34.7M | Sell |
431,430
-15,256
| -3% | -$1.22M | 1.37% | 8 |
|
|
2019
Q2 | $35.7M | Buy |
446,686
+3,616
| +0.8% | +$277K | 1.37% | 11 |
|
|
2019
Q1 | $35.2M | Buy |
443,070
+5,449
| +1% | +$408K | 1.46% | 13 |
|
|
2018
Q4 | $31.9M | Buy |
437,621
+159,086
| +57% | +$11.2M | 1.47% | 12 |
|
|
2018
Q3 | $18.9M | Sell |
278,535
-25,012
| -8% | -$1.59M | 0.71% | 27 |
|
|
2018
Q2 | $17.6M | Sell |
303,547
-18,108
| -6% | -$1.02M | 0.61% | 31 |
|
|
2018
Q1 | $16.7M | Sell |
321,655
-167,723
| -34% | -$9.06M | 0.56% | 40 |
|
|
2017
Q4 | $26.3M | Buy |
489,378
+163,334
| +50% | +$9.06M | 0.89% | 23 |
|
|
2017
Q3 | $19.9M | Sell |
326,044
-24,697
| -7% | -$1.5M | 1.13% | 13 |
|
|
2017
Q2 | $21.4M | Sell |
350,741
-117,080
| -25% | -$7.13M | 1.29% | 8 |
|
|
2017
Q1 | $28.4M | Buy |
+467,821
| New | +$28.4M | 1.33% | 12 |
|
Other funds holding MRK
LMFP
ATO
QP
Achmea Investment Management's MRK Position: Q2 2026 in Review
Achmea Investment Management reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $1.81M and leaving 115,829 shares worth $14.9M. The position accounts for 0.37% of the portfolio, ranked #67.
Achmea Investment Management first reported a position in MRK in Q1 2017 and has held it in 37 quarters since. The position peaked at $91.9M in Q1 2020. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Achmea Investment Management held 115,829 shares of Merck worth $14.9M as of Q2 2026.
- Achmea Investment Management sold 15,448 Merck shares in Q2 2026, an estimated $1.81M.
- Merck made up 0.37% of Achmea Investment Management's portfolio in Q2 2026, its #67 holding.
- Achmea Investment Management first reported a position in Merck in Q1 2017 and has held it in 37 quarters since.
- Achmea Investment Management's Merck position peaked at $91.9M in Q1 2020.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Achmea Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.